ги́бкость [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2013-09-03 23:16 (4676 d 09:45 ago) – Posting: # 11421
Views: 11,896

Hi Dan,

❝ Does anybody have experience with Russian authorities?


A little bit. I know one of the scientific advisors responsible for the BE guidance. Very knowledgable person, mathematical statistician, and specialised in Population PK.

❝ I never met anybody who submitted a dossier but there are a some people who like to discuss what would happen if......

❝ Out of curiosity: have you ever tried to find a phase I CRO in Russia?


Not personally but I know one company succeeding. Took them two years, opening up an office in Moscow, a lot of site visits, mock-up inspections, and trainings. The clinical phase of the first study ran last autumn.

❝ I could not identify one site which could conduct bioequivalence studies in a way we are used to it.


Define “the way you are used to it”. :-D An important term in Russia is “flexibility” – which has a long and valuable tradition.As you see from these examples this tradition of flexibility sits deep and you can expect to receive surprised looks when talking about the formalisms of GxP.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
117 visitors (0 registered, 117 guests [including 13 identified bots]).
Forum time: 09:01 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5